慶應義塾研究者情報データベース

その他の所属・職名 【 表示 ／ 非表示 】

その他の所属・職名 【 表示 ／ 非表示 】

• 先導研究センター, 先導研究センター（信濃町）

経歴 【 表示 ／ 非表示 】

経歴 【 表示 ／ 非表示 】

• 1989年05月

  -

  1990年04月

  慶應義塾大学病院・研修医（外科学教室）

• 1990年05月

  -

  1991年04月

  東京都済生会中央病院・研修医（外科）

• 1991年05月

  -

  1993年04月

  慶應義塾大学医学部・助手（救急部）

• 1993年05月

  -

  1995年04月

  済生会神奈川県病院・神奈川県交通救急センター・医員（救急部）

• 1995年05月

  -

  1998年04月

  慶應義塾大学医学部・助手（救急部）

全件表示 >>

学歴 【 表示 ／ 非表示 】

学歴 【 表示 ／ 非表示 】

• 1989年03月

  慶應義塾大学, 医学部

  大学, 卒業

学位 【 表示 ／ 非表示 】

学位 【 表示 ／ 非表示 】

• 博士（医学）, 慶應義塾大学, 論文, 2003年07月

  外科的侵襲下における生体反応機構の研究

免許・資格 【 表示 ／ 非表示 】

免許・資格 【 表示 ／ 非表示 】

• 日本救急医学会　指導医, 2006年01月

• 救急科専門医, 1994年01月

• 社会医学系専門医協会　社会医学系指導医・専門医

• ICD (Infection Control Doctor)

• 日本外科感染症学会 外科周術期感染管理認定医・教育医

全件表示 >>

研究分野 【 表示 ／ 非表示 】

研究分野 【 表示 ／ 非表示 】

• ライフサイエンス / 救急医学 （Emergency Medicine）

• ライフサイエンス / 麻酔科学 （集中治療医学）

• ライフサイエンス / 外科学一般、小児外科学 （外傷学）

• ライフサイエンス / 感染症内科学 （感染制御）

研究キーワード 【 表示 ／ 非表示 】

研究キーワード 【 表示 ／ 非表示 】

• 外傷

• 外科侵襲

• 感染制御

• 熱傷

研究テーマ 【 表示 ／ 非表示 】

研究テーマ 【 表示 ／ 非表示 】

• 外科的侵襲下における生体反応機構の研究, 

  1995年05月

  -

  継続中

論文 【 表示 ／ 非表示 】

論文 【 表示 ／ 非表示 】

• Risk of Developing Lower Limb Ischemia in Patients With Extracorporeal Cardiopulmonary Resuscitation: A Secondary Analysis of the Study of Advanced Cardiac Life Support for Ventricular Fibrillation With Extracorporeal Circulation in Japan II (SAVE-J II) Study

  Matsumura K., Yamamoto R., Kaito D., Homma K., Inoue A., Hifumi T., Sakamoto T., Kuroda Y., Sasaki J.

  Critical Care Medicine 54 （ 3 ） 484 - 495 2026年03月

  　概要を見る

  OBJECTIVES: While potential risks for limb ischemia have been explored in studies of venoarterial extracorporeal membrane oxygenation (ECMO), they remain inadequately defined for patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR). We identified risk factors for the development of lower limb ischemia during ECPR using a large nationwide ECPR cohort. DESIGN: A post hoc analysis was conducted using a nationwide, multicenter, retrospective study (Study of Advanced Cardiac Life Support for Ventricular Fibrillation with Extracorporeal Circulation in Japan II [SAVE-J II]). SETTING: Thirty-six institutions from 2013 to 2018. PATIENTS: Adult patients who underwent ECPR for out-of-hospital cardiac arrest.None. MEASUREMENTS AND MAIN RESULTS: Lower limb ischemia was defined as the requirement for a therapeutic distal perfusion catheter (DPC), fasciotomy, or amputation. Risk factors for lower limb ischemia were assessed using multivariate logistic regression models that included patient characteristics, ECPR-related information, and resuscitation content as potential confounders. Of the 969 patients, 72 (7.4%) developed lower limb ischemia. No significant differences were observed regarding background characteristics, cannulation location, puncture method, or venoarterial ECMO catheter size between patients with and without limb ischemia. However, a prophylactic DPC was less frequently employed in patients with lower limb ischemia than in those without (4 [5.6%] vs. 219 [24.4%]; p < 0.001). Higher incidences of cannulation-related bleeding and cannula malposition were observed in patients with limb ischemia than in those in patients without limb ischemia (22 [30.6%] vs. 162 [18.1%]; p = 0.009 and 9 [12.5%] vs. 29 [3.2%]; p < 0.001, respectively). Multivariable analyses revealed that prophylactic DPC placement was associated with a lower risk of limb ischemia (0.20 [0.07-0.55]; p = 0.002), whereas cannulation-related bleeding and cannula malposition were linked to an increased risk of lower limb ischemia (1.83 [1.06-3.14]; p = 0.030 and 3.81 [1.68-8.64]; p = 0.001, respectively). CONCLUSIONS: Lower limb ischemia during ECPR would be anticipated in patients with cannulation-related complications, and prophylactic DPC placement may be considered to mitigate the risk of lower limb ischemia.

  • Access to Document (DOI)

• Hydrogen Molecule Delivery System to Ischemic Intestine Using Resuscitative Endovascular Balloon Occlusion of Aorta in Hemorrhagic Shock—A Proof-of-Concept Study

  Yamanaka T., Matsuoka T., Homma K., Tamura T., Suzuki S., Suzuki S., Kaito D., Yoshizawa J., Yajima K., Ono S., Maeshima K., Kobayashi E., Sano M., Sasaki J.

  Biomedicines 14 （ 2 ）  2026年02月

  　概要を見る

  Background: The use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for hemorrhagic shock in the torso has become increasingly common as a bridge to definitive hemostasis. Hydrogen molecules, distributed throughout the bloodstream, alleviate ischemic injury but cannot reach ischemic organs during REBOA use. This study investigates whether intra-aortic irrigation with hydrogen-dissolved saline under REBOA use delivers hydrogen to the intestine in a swine hemorrhagic shock model. Methods: We induced volume-regulated hemorrhagic shock in a 40 kg female swine. Following this, hydrogen-dissolved saline irrigation was initiated through an intra-aortic catheter positioned distal to the REBOA balloon. Hydrogen concentration in the portal vein was determined in four models: controlled hemorrhagic shock with full REBOA inflation during the standard occlusion time, uncontrolled hemorrhagic shock with liver injury and full REBOA inflation during the extended occlusion time, uncontrolled hemorrhagic shock with liver injury and partial REBOA inflation during the extended occlusion time, and as the control model, controlled hemorrhagic shock with full REBOA inflation during the standard occlusion time with normal saline irrigation without hydrogen. Results: Hydrogen concentration in the portal vein was found to be 0.224 mg/L (13.998%) in the controlled hemorrhagic shock model with full REBOA inflation, 0.049 mg/L (3.063%) in the uncontrolled hemorrhagic shock model with liver injury and full REBOA inflation, 0.018 mg/L (1.125%) in the uncontrolled hemorrhagic shock model with liver injury and partial REBOA inflation, and 0.002 mg/L (0.015%) in the control model. These results demonstrate the presence of hydrogen in the portal vein under different REBOA applications. Conclusions: Increased hydrogen concentration in the portal vein indicated that hydrogen was delivered to the intestine. These findings suggest an approach for drug administration during REBOA use. However, further investigations are required to establish its application in clinical settings.

  • Access to Document (DOI)

• Impact of prophylactic drain placement on intra-abdominal infections after gastrectomy: nationwide inpatient database study in Japan

  Kouzu K., Aso S., Hirano Y., Matsui H., Fushimi K., Kitagawa H., Kato T., Yamane N., Hagiwara O., Miyoshi N., Matsuda S., Maruyama H., Morikane K., Sasaki J., Yasunaga H., Kitagawa Y., Tsujimoto H.

  Gastric Cancer 29 （ 1 ） 230 - 237 2026年01月

  ISSN  14363291

  　概要を見る

  Objective: This study aimed to evaluate the impact of drain placement on the incidence of postoperative complications in patients undergoing gastrectomy. Background: The effectiveness of prophylactic abdominal drain placement in gastrectomy remains unclear. Nevertheless, they are still commonly used following gastrectomy. Methods: We conducted a retrospective cohort study using a nationwide inpatient database in Japan. Patients who underwent gastrectomy for gastric cancer between January 2014 and March 2022 were included. We applied overlap weighting based on propensity scores to adjust for baseline characteristics. The primary outcome was the incidence of intra-abdominal infections. Secondary outcomes included postoperative percutaneous drainage, in-hospital death, length of hospital stay, and total hospitalization costs. Results: A total of 217,750 patients met the inclusion criteria, and 196,660 (90.3%) received prophylactic abdominal drains. After overlap weighting, the drain group had a significantly lower incidence of intra-abdominal infections compared to the no-drain group (6.3% vs. 7.6%; 95% confidence interval [CI] − 1.7 to − 1.0). The prophylactic drains were also associated with reduced in-hospital postoperative mortality (0.6% vs. 0.8%; 95% CI − 0.3 to − 0.1). No significant differences were observed between the two groups in postoperative percutaneous drainage or hospital stay duration. Conclusion: This study suggests that prophylactic abdominal drainage was associated with a reduced incidence of intra-abdominal infections after gastrectomy without increasing hospitalization duration or medical costs.

  • Access to Document (DOI)

• The risks and benefits of disseminated intravascular coagulation-targeted anticoagulant therapy in abdominal sepsis

  Matsuoka T., Yamakawa K., Ushio N., Hisamune R., Homma K., Sasaki J.

  Thrombosis Research 257 2026年01月

  ISSN  00493848

  　概要を見る

  Background: Abdominal sepsis frequently leads to disseminated intravascular coagulation (DIC), exacerbating organ dysfunction and bleeding complications. Although anticoagulant therapy is a potential treatment for DIC, its use in this context raises concerns about bleeding risks. Objectives: The purpose of this study is to investigate the risks and benefits of DIC-targeted anticoagulant therapy in patients with abdominal sepsis. Methods: Data were analyzed from a dataset from a multicenter nationwide retrospective cohort study (J-Septic DIC registry) in Japan between 2011 and 2013. The study included 987 patients with abdominal sepsis-induced DIC, diagnosed within three days of ICU admission. Patients were divided into DIC-targeted anticoagulant therapy (recombinant thrombomodulin or antithrombin) and non-use groups. Propensity score matching was used to adjust for confounding factors. The primary outcome was all-cause 90-day mortality, with bleeding complications requiring blood transfusion as the primary safety outcome. Results: The results indicated that anticoagulant therapy was associated with improved survival (hazard ratio: 0.662, 95 % confidential interval: 0.472–0.929), but a higher risk of bleeding complications (OR: 2.451, 95 % confidential interval:1.372–4.379). Dual combination of anticoagulant therapy did not provide additional survival benefits and increased bleeding risks. The efficacy of DIC-targeted anticoagulant therapy correlated with disease severity, while bleeding risk was inversely correlated with severity. Conclusion: DIC-targeted anticoagulant therapy in patients with abdominal sepsis was related with improved prognosis but increased bleeding risks. The risk-benefit profile varies with disease severity, suggesting a need for cautious and personalized treatment strategies.

  • Access to Document (DOI)

• Effect of Broad-Spectrum Antibiotic Prophylaxis on Post-Pancreatoduodenectomy Infectious Complications: Nationwide Inpatient Database Study in Japan

  Kitagawa H., Aso S., Hirano Y., Uemura K., Kouzu K., Matsuda S., Matsui H., Fushimi K., Sasaki J., Kitagawa Y., Yasunaga H.

  Annals of Gastroenterological Surgery 2026年

  　概要を見る

  Background: Despite improvements in surgical techniques and perioperative management, the incidence of postoperative surgical site infection after pancreatoduodenectomy remains high. This study aim to assess whether broad-spectrum antibiotic prophylaxis can reduce complications after pancreatoduodenectomy compared with standard care antibiotics. Methods: Data of patients who underwent pancreatoduodenectomy between July 2010 and March 2022 were extracted from a nationwide Japanese inpatient database. First- and second-generation cephalosporins were designated as narrow-spectrum, and third- and fourth-generation cephalosporins and piperacillin–tazobactam as broad-spectrum antibiotics. Patients who received either narrow- or broad-spectrum antibiotics on the day of surgery were included in the analysis. Using propensity-score stabilized inverse probability of treatment weighting, the postoperative complications were compared between patients who received antimicrobial prophylaxis with narrow-spectrum antibiotics versus broad-spectrum antibiotics. Results: From among 45 099 eligible patients, 36 742 (81.5%) and 8357 (18.5%) patients received narrow- and broad-spectrum antibiotics, respectively. After stabilized inverse probability of treatment weighting, the use of broad-spectrum antibiotics bore a significant association with the reduction in intra-abdominal infections [risk difference (RD), −7.4; 95% confidence interval (CI), −8.7 to −6.0], postoperative pancreatic fistula (RD, −3.0; 95% CI, −4.0 to −1.9), post-pancreatectomy hemorrhage (RD, −1.5; 95% CI, −1.9 to −1.1). The use of broad-spectrum antibiotics was also associated with a shorter postoperative length of hospital stay and lower total hospitalization costs. The proportion of Clostridioides difficile infection did not differ between the groups. Conclusions: The administration of broad-spectrum antibiotics as antimicrobial prophylaxis was associated with better in-hospital postoperative outcomes compared with narrow-spectrum in patients undergoing pancreatoduodenectomy.

  • Access to Document (DOI)

全件表示 >>

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

• オミクス解析から心停止症候群の病態を解明し新規治療法を開発する

  佐々木, 淳一

  科学研究費補助金研究成果報告書 2023年

• 造影剤投与による急性腎障害の機序解明および医薬応用

  佐々木, 淳一

  科学研究費補助金研究成果報告書 2020年

総説・解説等 【 表示 ／ 非表示 】

総説・解説等 【 表示 ／ 非表示 】

• A second update on mapping the human genetic architecture of COVID-19

  Kanai M., Andrews S.J., Cordioli M., Stevens C., Neale B.M., Daly M., Ganna A., Pathak G.A., Iwasaki A., Karjalainen J., Mehtonen J., Pirinen M., Chwialkowska K., Trankiem A., Balaconis M.K., Veerapen K., Wolford B.N., Ahmad H.F., von Hohenstaufen Puoti K.A., Boer C., Boua P.R., Butler-Laporte G., Cadilla C.L., Colombo F., Douillard V., Dueker N., Dutta A.K., El-Sherbiny Y.M., Eltoukhy M.M., Esmaeeli S., Faucon A., Fave M.J., Cadenas I.F., Francescatto M., Francioli L., Franke L., Fuentes M., Durán R.G., Cabrero D.G., Harry E.N., Jansen P., Szentpéteri J.L., Kaja E., Kirk C., Kousathanas A., Krieger J.E., Patel S.K., Lemaçon A., Limou S., Lió P., Marouli E., Marttila M.M., Medina-Gómez C., Michaeli Y., Migeotte I., Mondal S., Moreno-Estrada A., Moya L., Nakanishi T., Nasir J., Pasko D., Pearson N.M., Pereira A.C., Priest J., Prijatelj V., Prokic I., Teumer A., Várnai R., Romero-Gómez M., Roos C., Rosenfeld J., Ruolin L., Schulte E.C., Schurmann C., Sedaghati-khayat B., Shaheen D., Shivanathan I., Sipeky C., Sirui Z., Striano P., Tanigawa Y., Remesal A.U., Vadgama N., Vallerga C.L., van der Laan S., Verdugo R.A., Wang Q.S., Wei Z., Zainulabid U.A., Zárate R.N., Auton A., Shelton J.F., Shastri A.J., Weldon C.H., Filshtein-Sonmez T., Coker D., Symons A.

  Nature 621 （ 7977 ） E7 - E26 2023年09月

  ISSN  00280836

  • Access to Document (DOI)

• Reply to Swinging the pendulum in prehospital trauma mortality needs a more holistic approach

  Yamamoto R., Suzuki M., Sasaki J.

  Journal of Trauma and Acute Care Surgery 91 （ 3 ） E81 - E82 2021年09月

  ISSN  21630755

  • Access to Document (DOI)

• Reply to Methodological issues on developing a novel scale for prediction of delayed intubation in patients with inhalation injury

  Yamamoto R., Matsumura K., Sasaki J.

  Burns 47 （ 1 ）  2021年02月

  ISSN  03054179

  • Access to Document (DOI)

競争的研究費の研究課題 【 表示 ／ 非表示 】

競争的研究費の研究課題 【 表示 ／ 非表示 】

• 心停止蘇生後患者のバイオバンクを機転とするリバーストランスレーショナル・リサーチ

  2024年04月

  -

  2027年03月

  佐々木 淳一, 基盤研究(B), 補助金,  研究代表者

• オミクス解析から心停止症候群の病態を解明し新規治療法を開発する

  2021年04月

  -

  2024年03月

  文部科学省・日本学術振興会, 科学研究費助成事業, 佐々木 淳一, 基盤研究(C), 補助金,  研究代表者

• 造影剤投与による急性腎障害の機序解明および医薬応用

  2018年04月

  -

  2021年03月

  文部科学省・日本学術振興会, 科学研究費助成事業, 佐々木　淳一, 基盤研究(C), 補助金,  研究代表者

担当授業科目 【 表示 ／ 非表示 】

担当授業科目 【 表示 ／ 非表示 】

• 救急医学講義

  2026年度

• 救急医学・救急看護

  2026年度

• 救急医学臨床実習

  2026年度

• 救急医学演習

  2026年度

• 研究臨床体験プログラム

  2026年度

全件表示 >>

担当経験のある授業科目 【 表示 ／ 非表示 】

担当経験のある授業科目 【 表示 ／ 非表示 】

• 医療系三学部合同教育

  慶應義塾

  2015年04月

  -

  2016年03月

• 看護医療学部　救急医学・救急看護

  慶應義塾

  2015年04月

  -

  2016年03月

• 医学部　救急医学

  慶應義塾

  2015年04月

  -

  2016年03月

所属学協会 【 表示 ／ 非表示 】

所属学協会 【 表示 ／ 非表示 】

• 日本救急医学会

  　

委員歴 【 表示 ／ 非表示 】

委員歴 【 表示 ／ 非表示 】

• 2023年10月

  -

  継続中

  連携会員, 日本学術会議

• 2008年01月

  -

  継続中

  専門委員, 独立行政法人医薬品医療機器総合開発機構（PMDA）